Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Equity Ratio (2016 - 2025)

Xtant Medical Holdings has reported Equity Ratio over the past 16 years, most recently at 0.54 for Q4 2025.

  • Quarterly Equity Ratio rose 18.21% to 0.54 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.54 through Dec 2025, up 18.21% year-over-year, with the annual reading at 0.54 for FY2025, 18.21% up from the prior year.
  • Equity Ratio was 0.54 for Q4 2025 at Xtant Medical Holdings, up from 0.47 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.59 in Q3 2023 and troughed at 0.46 in Q4 2024.
  • The 5-year median for Equity Ratio is 0.54 (2022), against an average of 0.53.
  • The largest YoY upside for Equity Ratio was 152.04% in 2021 against a maximum downside of 48.31% in 2021.
  • A 5-year view of Equity Ratio shows it stood at 0.56 in 2021, then grew by 0.47% to 0.57 in 2022, then dropped by 2.27% to 0.55 in 2023, then dropped by 17.42% to 0.46 in 2024, then grew by 18.21% to 0.54 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Equity Ratio are 0.54 (Q4 2025), 0.47 (Q3 2025), and 0.47 (Q2 2025).